4
Changes in Ownership
Cullinan Therapeutics, Inc. Filed Acc 0001193125-26-064261
Chief Financial Officer sold 4,398 shares at $13.62 ($59,901)
From the SEC's structured data for this filing
Trades in this filing
Fenton Mary Kay · Chief Financial Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-02-20 | Sale : show line 1 in the form | −4,398 | $13.62 | $59,901 | 126,380 | D |
| Open-market sales · 4,398 sh · avg $13.62 · $59,901 | ||||||
Loading xslF345X05/ownership.xml…